Clinical implications of genetic advances in Charcot–Marie–Tooth disease
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical implications of genetic advances in Charcot–Marie–Tooth disease
Authors
Keywords
-
Journal
Nature Reviews Neurology
Volume 9, Issue 10, Pages 562-571
Publisher
Springer Nature
Online
2013-09-10
DOI
10.1038/nrneurol.2013.179
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Disease-targeted sequencing: a cornerstone in the clinic
- (2013) Heidi L. Rehm NATURE REVIEWS GENETICS
- Rapidly progressive asymmetrical weakness in Charcot–Marie–Tooth disease type 4J resembles chronic inflammatory demyelinating polyneuropathy
- (2013) Ellen Cottenie et al. NEUROMUSCULAR DISORDERS
- Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice
- (2012) Ágnes Patzkó et al. BRAIN
- Recommendations for the predictive genetic test in Huntington's disease
- (2012) R MacLeod et al. CLINICAL GENETICS
- Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort
- (2012) G. L. Davidson et al. JOURNAL OF NEUROLOGY
- Charcot–Marie–Tooth disease: frequency of genetic subtypes and guidelines for genetic testing
- (2012) Sinead M Murphy et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Idiopathic neuropathy: new paradigms, new promise
- (2012) Mike A. Singer et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Re-analysis of an originalCMTX3family using exome sequencing identifies a knownBSCL2mutation
- (2012) Rabia Chaudhry et al. MUSCLE & NERVE
- Exome sequencing identifies a novel TRPV4 mutation in a CMT2C family
- (2012) G. Landoure et al. NEUROLOGY
- Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease
- (2012) R. D. S. Pitceathly et al. NEUROLOGY
- Charcot-marie-tooth disease subtypes and genetic testing strategies
- (2011) Anita S.D. Saporta et al. ANNALS OF NEUROLOGY
- Oral l-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1
- (2011) Kevin Garofalo et al. JOURNAL OF CLINICAL INVESTIGATION
- Charcot-Marie-Tooth disease
- (2011) Mary M. Reilly et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial
- (2011) Davide Pareyson et al. LANCET NEUROLOGY
- Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss
- (2011) Christopher J Klein et al. NATURE GENETICS
- HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1–induced Charcot-Marie-Tooth disease
- (2011) Constantin d'Ydewalle et al. NATURE MEDICINE
- What can we learn from the history of Charcot-Marie-Tooth disease?
- (2010) Robert Ouvrier DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Whole-Genome Sequencing in a Patient with Charcot–Marie–Tooth Neuropathy
- (2010) James R. Lupski et al. NEW ENGLAND JOURNAL OF MEDICINE
- GJB1 gene mutations in suspected inflammatory demyelinating neuropathies not responding to treatment
- (2009) A W Michell et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Ascorbic acid for Charcot–Marie–Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial
- (2009) Joshua Burns et al. LANCET NEUROLOGY
- Effect of ascorbic acid in patients with Charcot–Marie–Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial
- (2009) Joëlle Micallef et al. LANCET NEUROLOGY
- The phenotype of Charcot–Marie–Tooth disease type 4C due to SH3TC2 mutations and possible predisposition to an inflammatory neuropathy
- (2009) Henry Houlden et al. NEUROMUSCULAR DISORDERS
- Mutations in the HSP27 (HSPB1) gene cause dominant, recessive, and sporadic distal HMN/CMT type 2
- (2008) H. Houlden et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search